|
|
|
|
Document Preview Settlement Agreement |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Settlement Agreement |
|||
|
Entities: |
||||
|
Date: |
2004 |
|||
|
Size: |
Preview shows 4KB of 18KB total |
|||
|
Price: |
$33 |
|||
|
ID: |
#306672 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF MICHIGAN
SOUTHERN DIVISION
BIOTHERAPIES, INC.,
a Michigan Corporation Civil Action No. 03-74679
and, Magistrate Judge. R. Steven Whalen
PAUL R. ERVIN, JR. PRESIDENT District Judge AVERN COHN
A Michigan Corporation
Plaintiffs and Counter-Defendants
v
GENESIS BIOVENTURES, INC.,
A NEW YORK CORPORATION,
and,
E. GREG McCARTNEY, PRESIDENT
Defendants and Counter-Plaintiffs
Garcile E. Bailey (P32601)
Attorney for Biotherapies, Inc.
P. O. Box 8341
Ann Arbor, Michigan, 48107
(303) 923-1461
PAUL ERVIN, Pro Se
3447 Cummings Road
Ann Arbor, Michigan, 48105
WILLIAM M. DONOVAN P12892
Attorney for Defendants
420 West University Drive
Rochester, Michigan, 48307
(Tel) 248-601-4284
(Fax) 248-656-5751
SETTLEMENT AGREEMENT
--------------------
{PAGE}
This Settlement Agreement is made effective as of June ___, 2004, by and
among Biotherapies, Inc., a Michigan Corporation ("Biotherapies"); Paul R.
Ervin, Jr. ("Mr. Ervin," and together with Biotherapies, the "Plaintiffs");
Genesis Bioventures, Inc., a New York Corporation ("Genesis Bioventures"); and
E. Greg McCartney ("Mr. McCartney");
WHEREAS, there is presently pending in the United States District Court,
Eastern District of Michigan, Southern Division, Case No: 03-74679, an action
entitled Biotherapies, Inc, and Paul R. Ervin, Jr. as Plaintiffs and
Counter-Defendants and Genesis Bioventures, Inc. and E. Greg McCartney,
Defendants and Counter-Plaintiffs (the "Action"); and
WHEREAS, the parties hereto have arrived upon a basis of settlement of the
Action and certain other matters, all in accordance with the following terms and
conditions.
NOW, THEREFORE, this Settlement Agreement provides as follows:
IN CONSIDERATION of the promises, covenants and undertakings herein contained,
the adequacy of which is hereby confessed and acknowledged by each of the
parties hereto, and with the knowledge that there is a pending Amended and
Restated Agreement and Plan of Merger between Genesis Bioventures and Corgenix
Medical Corporation (the "Merger Agreement"), the parties agree as follows:
1. All of the parties will immediately and contemporaneously dismiss
their claims Without Prejudice in the form as the attached Stipulation and Order
to Dismiss (Exhibit A).
2. Upon execution of this Settlement Agreement and the Stipulated Order to
Dismiss, Biotherapies shall be permitted to sell and transfer any and all of the
common stock of Genesis Bioventures that it owns; provided that Biotherapies
shall not sell or offer to sell more than Two Hundred Thousand (200,000) Genesis
Bioventures common shares in any one (1) month; provided, however, that
beginning on the date that is six (6) months after the Effective Time of the
|
End of Preview |
Home Intelligence Services Subscriptions News About Us